close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about REspiratory syncytial virus

Recent news which mentions REspiratory syncytial virus

Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Tags Sanofi SA GSK plc Pharmaceuticals
From CNBC.com News
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
Tags Vaccinations Business News Moderna Inc
From CNBC.com News
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
Tags Pharmaceuticals GSK plc Breaking news
From CNBC.com News
RSV vaccine from GSK shows potential to protect adults 50 to 59
Tags Business Biotechnology Immunizations
From CNBC.com News
CDC advisors recommend Pfizer maternal RSV vaccine to protect infants
Tags Sanofi SA Social issues Pharmaceuticals
From CNBC.com News
FDA approves Pfizer maternal RSV vaccine for infants
Tags Companies Health care industry Respiratory syncytial virus
From CNBC.com News
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
Tags Business Biotechnology Health & Science
From CNBC.com News
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
Tags Respiratory syncytial virus Companies Health care industry
From CNBC.com News
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
Tags Business Biotechnology Immunizations
From CNBC.com News
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
Tags Pfizer Inc Business News Vaccinations
From CNBC.com News
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults over 60
Tags GSK plc Social issues Pharmaceuticals
From CNBC.com News
GSK says RSV vaccine for older adults provides protection over two seasons
Tags Vaccine controversy Business News Vaccinations
From CNBC.com News
Pfizer RSV vaccine for older adults is only slightly less effective after 18 months
Tags Pfizer Inc Business News Biotech and Pharmaceuticals
From CNBC.com News
FDA approves Pfizer RSV vaccine for older adults
Tags Biotechnology Disease outbreaks Business
From CNBC.com News
Here’s what Pfizer and Moderna say is next for their Covid vaccines
Tags Health & Science Respiratory syncytial virus Health care industry
From CNBC.com News
FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
Tags Business News Vaccinations Pfizer Inc
From CNBC.com News
Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say
Tags Respiratory syncytial virus Companies Health care industry
From CNBC.com News
FDA approves GSK's RSV vaccine for older adults, world's first shot against virus
Tags Moderna Inc Vaccinations Pfizer Inc
From CNBC.com News
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adults
Tags Disease outbreaks Business Biotechnology
From CNBC.com News
Moderna, Pfizer's new race: The RSV vaccine FDA approval process
Tags Immunizations CNBC Disruptor 50 Respiratory syncytial virus
From CNBC.com News
A nutritionist shares the best snacks to bring on a plane to boost your immune system
Tickers LIFE
Tags Coronavirus Flu Hospitality and leisure industry
From CNBC.com News
Why flu season is so bad this year
Tickers LIFE
Tags Children Politics Biotech and Pharmaceuticals
From CNBC.com News
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data shows
Tags Epidemics Coronavirus Pfizer Inc
From CNBC.com News
Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV
Tickers AZN AZNCF SNY
Tags SNY Large Cap AZNCF
From Benzinga
Pfizer's RSV Vaccine Candidate Receives FDA Breakthrough Therapy Tag For Prevention of RSV In Older Adults
Tickers PFE
Tags PFE Briefs Health Care
From Benzinga
Johnson & Johnson Posts Additional RSV Vaccine Data
Tickers JNJ
Tags Health Care News JNJ
From Benzinga
J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults
Tickers JNJ
Tags Phase 2 Trial Briefs JNJ
From Benzinga
Pfizer Starts Late-Stage Trial For RSV Vaccine Candidate In Older Patients
Tickers PFE
Tags Biotech Market News General
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.